Popular Aspirin News and Current Events

Popular Aspirin News and Current Events, Aspirin News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 25 | 1000 Results
Aspirin before at-home colorectal cancer screening test didn't significantly improve ability to detect cancer precursors
Some observational studies have suggested that taking aspirin before undergoing colorectal cancer screening with a fecal immunochemical test for blood in stool might improve the ability of the test to detect cancer precursors. (2019-05-07)

How humans and their gut microbes may respond to plant hormones
A bowl of salad contains more than vitamins and minerals. Plant matter also includes remnants of the hormones plants produce to control how they grow, age, and manage water intake. Recently, scientists have reported that our gut microbes and cells may respond to these hormones and even produce similar molecules of their own. In an opinion article published in Trends in Plant Science, researchers in France explore how plant hormones may influence human health. (2017-08-22)

Molecular 'magnets' could improve cancer immunotherapy
Chemicals that attract specialised immune cells toward tumours could be used to develop better immunotherapies for cancer patients, according to new research published in Cell. Scientists at the Francis Crick Institute have discovered that immune cells called Natural Killer cells accumulate in tumours and release chemicals that attract specialised dendritic cells (cDC1) - white blood cells known for triggering anti-cancer immune responses - to the tumour. (2018-02-08)

NIH report on intracranial stent points out need for upcoming large-scale clinical trial
A preliminary study funded by the National Institutes of Health found that a stent designed to open clogged arteries in the brain was successfully deployed in nearly all cases and significantly reduced arterial blockage in the short term. But data on the long-term benefit of the stent, compared to medical treatment alone, were inconclusive, prompting the upcoming launch of a large-scale randomized trial that is expected to provide definitive results. (2008-02-13)

Heart attack risk increases with six-month dual antiplatelet therapy
The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome (ACS) who were randomly assigned to receive dual antiplatelet therapy (DAPT) for either six months or at least 12 months after receiving a drug-eluting stent. (2018-03-12)

Elevated blood pressure before pregnancy may increase chance of pregnancy loss
Elevated blood pressure before conception may increase the chances for pregnancy loss, according to an analysis by researchers at the National Institutes of Health. The authors conclude that lifestyle changes to keep blood pressure under control could potentially reduce the risk of loss. The study appears in Hypertension. (2018-04-02)

Preeclampsia screening method found superior to current tests
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. (2018-03-14)

Daily low-dose aspirin found to have no effect on healthy life span in older people
In a clinical trial to determine the effects of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living free of dementia or physical disability. These findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, partially supported by the National Institutes of Health, were published online on September 16, 2018 in three papers in The New England Journal of Medicine. (2018-09-16)

Safety of bioabsorbable polymer against durable polymer DES in high-risk PCI patients
A novel study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) presented a safety advantage without compromising efficacy compared to durable polymer (DP) formulations. Subgroup findings from the TWILIGHT trial were presented today during the SCAI 2020 Scientific Sessions Virtual Conference. (2020-05-14)

Common painkillers lower levels of prostate cancer biomarker
Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer. But the authors of the study caution that men shouldn't take the painkillers in an effort to prevent prostate cancer just yet. (2008-09-08)

Higher blood pressure before pregnancy may increase miscarriage risk
Higher blood pressure prior to conception may increase the risk of miscarriage, even in women not diagnosed with hypertension. The study involved women who had already experienced at least one pregnancy loss and were trying again. If confirmed, the findings imply that lowering heart disease risk factors in young adulthood may also improve reproductive health. (2018-04-02)

Immediate aspirin after mini-stroke substantially reduces risk of major stroke
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events. Writing in the Lancet, the team say that immediate self-treatment when patients experience stroke-like symptoms would considerably reduce the risk of major stroke over the next few days. (2016-05-18)

Beijing pollution may trigger heart attacks, strokes
The heavily polluted air in Beijing may trigger serious cardiovascular problems for some spectators. Researchers from Northwestern University's Feinberg School of Medicine warn that for people in certain risk groups, breathing high levels of pollution can cause heart attacks and strokes within 24 hours of exposure and increase the possibility of having blood clots in their legs on the plane home. Northwestern research shows that high pollution levels cause hyperclotting of the blood, spurring stokes and heart attacks. (2008-07-21)

Anti-cancer flower power
Tel Aviv University researchers are combating cancer with a jasmine-based drug. (2008-08-25)

Obesity inhibits key cancer defense mechanism
Obesity could enhance cancer development while aspirin might prevent it -- a new insight into potential targets for cancer prevention. (2018-04-26)

Trial reveals differences in pain-relieving drugs when combined with aspirin
A landmark 2016 Cleveland Clinic study of widely used pain-relieving drugs showed that celecoxib (Celebrex) was associated with comparable cardiovascular safety and better gastrointestinal (GI) and kidney safety when compared with either naproxen (Naprosyn) and ibuprofen (Motrin). A new substudy analyzed outcomes in PRECISION based on the presence or absence of aspirin use with specific NSAIDs (nonsteroidal anti-inflammatory drugs). (2018-04-16)

Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects. (2018-04-19)

Common pain reliever can improve survival in head and neck cancer
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UC San Francisco has found. (2019-01-25)

Screening high-risk individuals can reduce multiple myeloma mortality
Multiple myeloma is a rare incurable disease that is diagnosed in more than 30,000 people each year in the United States. Only half of patients with multiple myeloma are expected to survive five years after their diagnosis. Moffitt Cancer Center researchers are trying to identify patients who are at a higher risk of developing multiple myeloma early in order to improve patient outcomes. (2018-03-27)

Aspirin, acid blocker a-day keeps GI bleeding
In a new study, University of Michigan researchers reveal that over-the-counter acid-blockers are worth the price for coronary heart disease patients taking low-dose aspirin as a preventative measure. (2008-08-11)

Solo medical practices outperform groups in treatment of cardiac disease
Solo primary care practices in New York City are more likely than group practices to meet practice guidelines for reducing cardiovascular risk. (2018-04-09)

When two is better than three: Dual antithrombotic therapy cuts bleeding risk
Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy. (2017-08-27)

Researchers find combination therapy works best for heart diseases
A major international study has found that the combination of two drugs -- rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in people with vascular disease. The study of 27,400 people with stable coronary or peripheral artery disease from 33 countries worldwide shows that the combination of 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin once daily was significantly better than only aspirin or only rivaroxaban in preventing heart attacks, strokes and death. (2017-08-27)

Stopping DAPT after one-month improved outcomes in stent patients
Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)

Study shows taking aspirin before or after coronary
New research presented at this year's Euroanaesthesia congress in Copenhagen, Denmark shows that in patients undergoing a coronary artery bypass graft (CABG) surgery, taking aspirin before and after surgery is associated with an 18 percent to 34 percent reduced mortality risk after four years. (2018-06-03)

Use of ibuprofen and similar NSAIDs may shorten life of patients
Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years. However, a new study in the journal Kidney Cancer indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma (mRCC). (2018-05-01)

Can aspirin treat Alzheimer's?
regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological researchers at Rush University Medical Center, who published the results of their study today in the July issue of The Journal of Neuroscience. (2018-07-02)

Aspirin and atherosclerosis
Researchers have uncovered the mechanism that may explain aspirin's ability to prevent arterial plaque buildup and atherosclerosis. (2008-09-22)

Use of 2 anti-clotting medications following bypass surgery improves outcomes for grafted veins
Taking aspirin plus an anti-clotting medication for one year after heart bypass surgery resulted in less narrowing of the vein used to bypass a blocked artery than taking aspirin alone. (2018-04-24)

ACC/AHA guidance for preventing heart disease, stroke released
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy eating plan, getting more exercise, avoiding tobacco and managing known risk factors are among the key recommendations in the 2019 Primary Prevention of Cardiovascular Disease guideline from the American College of Cardiology (ACC) and the American Heart Association (AHA). Also, it is recommended that aspirin should only rarely be used to help prevent heart attacks and stroke in people without known cardiovascular disease. (2019-03-18)

Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?
A research group from China investigated the mechanisms of aspirin increasing the susceptibility of Helicobacter pylori (H. pylori) to metronidazole. They found that although aspirin increases the susceptibility of H. pylori to metronidazole, it has no effect on the mutations of rdxA gene of H. pylori. Aspirin increases endocellular concentrations of antimicrobials and probably by altering the expression of the outer membrane proteins of H. pylori. (2009-03-03)

Rivaroxaban plus aspirin reduces adverse events (COMPASS)
Rivaroxaban plus aspirin reduces major adverse cardiovascular and limb events by nearly one-third in patients with peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line -- LBCT Session at ESC Congress. (2017-08-27)

Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke
The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients. (2019-02-06)

10 percent of Chinese adults have high heart disease risk, aren't treated for it
Researchers at Yale and at the National Center for Cardiovascular Disease in China just quantified a significant opportunity to improve Chinese heart health: 1 in 10 middle-aged Chinese adults are at high risk for heart disease, yet only about 3 percent of those at-risk are taking either statins or aspirin, the recommended therapies for managing that risk. This study was published in the Annals of Internal Medicine. (2019-02-21)

Stroke prevention drug combo shows promise, study says
If you've had a minor stroke or a transient ischemic stroke (TIA), taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days, according to new research published in The New England Journal of Medicine. (2018-05-16)

Aspirin's health benefits under scrutiny
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events. (2019-12-09)

Bleeding during endoscopy: Do anti-inflammatories play a role?
Does an aspirin-a-day increase the risk of bleeding during invasive diagnostic procedure? This is an important concern for many patients who take these and other antiplatelet agents in an effort to reduce heart attacks or strokes. Researchers at the MUHC have shown that antiplatelet drugs do not contribute to post-endoscopic bleeding. Their findings are published in this month's issue of Alimentary Pharmacology and Therapeutics. (2007-03-15)

'Invisible' stool blood linked to heightened risk of death from all causes
'Invisible' blood detected in the stools is linked to a heightened risk of death from all causes, as well as from bowel cancer, reveals research published online in the journal Gut. (2018-07-16)

Fighting cancer with aspirin?
When looking for new weapons in the war on cancer, scientists should turn to their medicine cabinets for an age-old remedy -- aspirin. Scientists at the University of Newcastle have determined that aspirin has cancer-fighting effects extending beyond Cox inhibitors. This finding, appearing in the October 2006 issue of the FASEB Journal, allows researchers to pursue new lines of investigation that could ultimately yield a new type of cancer-fighting drug. (2006-10-02)

Can aspirin decrease the rate of intracranial aneurysm growth?
Researchers investigated whether aspirin can aid in the prevention of intracranial aneurysm rupture by hindering aneurysm growth. The researchers identified 146 patients harboring multiple intracranial aneurysms, five millimeters or less in diameter, that had been observed for at least five years. In this set of patients, the researchers found an association between aspirin use and a decreased rate of aneurysm growth. Growth is important in intracranial aneurysms because it increases the risk of aneurysm rupture. (2019-10-29)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.